Fred Telling

CIK 1382225 · last filed 2026-01-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$588

Companies

3

Total Filings

78

Lifetime Open-Market Net

$146.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OGEN Director 948 $0.62 $588 $679.7K 33 2026-01-22
CTI BIOPHARMA CORP (CTIC) Delisted Director 78,874 $9.09 $717.0K $0 8 2018-09-20
CTI BIOPHARMA CORP (TRGT) Delisted Director 417,490 -$533.2K 29 2014-03-07

Recent Filings · Page 2 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-05-25 OGEN Buy (P) +82,173 $23.8K EDGAR
2022-05-23 OGEN Buy (P) +65,718 $18.6K EDGAR
2022-05-20 OGEN Buy (P) +72,109 $19.9K EDGAR
2022-04-01 OGEN Buy (P) +183,838 $66.1K EDGAR
2021-12-17 OGEN Grant (A) $0 EDGAR
2021-06-30 OGEN Exer (M) +156,540 $75.1K EDGAR
2021-02-19 OGEN Grant (A) $0 EDGAR
2020-11-25 OGEN Buy (P) +100,000 $37.0K EDGAR
2020-05-15 OGEN E $0 EDGAR
2020-02-07 OGEN Grant (A) $0 EDGAR
Showing 1120 of 78
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.